Brain protein deficiency promotes compulsive behaviour
12 September, 2023The absence of two proteins in mice, Intersectin1 and Intersectin2, leads to disrupted neural signalling and compulsive repetitive behaviour.
Reduced grey matter in frontal lobes linked to teenage smoking
06 September, 2023Levels of grey matter in two parts of the brain may be linked to a desire to start smoking during adolescence and the strengthening of nicotine addiction.
Inflammation slows malaria parasite growth in the body
04 September, 2023Inflammation in the body can slow down the development of malaria parasites in the bloodstream, which may prevent or limit severe disease.
RSV vaccine remains effective against distinct viral variants
28 August, 2023 by Lauren DavisGSK's Arexvy vaccine for RSV can remain effective against a range of variants and produces strong antibody responses against distinct viral strains.
New antibiotic sourced from 'microbial dark matter'
25 August, 2023A powerful new antibiotic, isolated from bacteria that could not be studied before, seems capable of combating harmful bacteria and even multi-resistant 'superbugs'.
Simple fragrance release boosts memory in elders
24 August, 2023Neuroscientists at the University of California, Irvine (UCI) have found that releasing aromas into the bedrooms of sleeping elders helps to increase cognitive capacity.
Hookworms could offer protection from severe COVID
21 August, 2023Mice infected with hookworm were less likely to develop severe COVID symptoms and recovered from the infection much more quickly than their counterparts.
RNA therapy activates dendritic cells to combat melanoma
15 August, 2023The RNA-based strategy activated dendritic cells that eradicated tumours and prevented their recurrence in mouse models of melanoma.
Vaccine candidate offers hope against EBV-associated diseases
11 August, 2023The new vaccine candidate offers a breakthrough approach that combines two powerful arms of the immune system to target Epstein–Barr virus in both acute and latent infection.
Probiotics could slow age-related cognitive decline
08 August, 2023US researchers have suggested that taking a probiotic could help prevent the decline in memory and thinking that can accompany aging.
Novel vaccine may reduce the impact of Alzheimer's disease
02 August, 2023A novel vaccine that targets inflamed brain cells associated with Alzheimer's disease may hold the key to potentially preventing or modifying the course of the disease.
Breastfeeding mums' diet may affect children's asthma risk
01 August, 2023A high-fibre diet in mothers helps to reduce the risk of infants developing severe lower respiratory infections, which can predispose the infant to chronic lung diseases.
Strep A primarily transmitted through bacteria in throat
31 July, 2023Group A Streptococcus infections are more likely transmitted from asymptomatic throat carriage than skin-to-skin contact in communities with high rates of infection.
Powerful mRNA vaccine to tackle malaria
24 July, 2023The mRNA-based vaccine can effectively target and stimulate protective immune cell responses against the malaria-causing parasite Plasmodium in preclinical models.
Genetic basis found for asymptomatic COVID-19 infection
21 July, 2023A person who carries one copy of the HLA-B15 gene is twice as likely to remain asymptomatic, while someone with two copies of the gene is eight times more likely to show no symptoms.
